Publication Month: Aug 2020 | Report Code: TIPRE00004921 | No. of Pages: 213 | Category: Medical Device | Status: Published
The closed system drug transfer devices protect hazardous drugs or vapors during drug preparation and administration. It comprises components that enable the filtering of dangerous vapors out of the system. Closed system drug transfer devices play a significant role in the protection of healthcare professionals from antineoplastic as well as other harmful medications. The growing emphasis on the implementation of occupational health and safety standards by government authorities are offering lucrative opportunity for the growth of the market. The closed system drug transfer devices market growth is mainly attributed to the growing adoption of chemotherapy and the improvement of regulatory guidelines regarding hazardous drugs. Moreover, the rising number of chemotherapeutic drug approvals is expected to foster market growth during the forecast period. However, the lack of regulatory guidelines regarding health workers' safety in emerging countries limits the market's development.
The market for Closed System Drug Transfer Device (CSTD) in Europe is positively affected. For instance, the necessity to divert healthcare staff and resources to address the pandemic has resulted in the suspension of cancer screening programs for asymptomatic patients in many countries. In March 2020, the Welsh government and the Scottish government suspended screening programs for breast, cervical, and bowel cancer.
Get more information on this report :
Several hazardous drugs, such as antineoplastics, monoclonal antibodies, and antibiotics, are used during patient treatment protocols. Pharmacists, physicians, nurses, and other healthcare workers are at significant risk of exposure to hazardous drugs. The cancer treatment comprises the utilization of antineoplastic medications that can cause several health implications if ingested. The antineoplastic can have a severe impact during pregnancies, and the exposure can lead to chromosomal abnormalities. The surface contamination of chemotherapy treatment can impact not only healthcare professionals but also patients and their families. An increasing number of cancer cases are anticipated to drive the adoption of chemotherapies across the globe. For instance, according to the World Health Organization (WHO), in 2018, ~9.6 million deaths were reported due to cancer worldwide. According to the study conducted by the American Cancer Society in 2019–2020, chemotherapy is the most common cancer treatment among stage III breast cancer women as ~56.0% of stage III breast cancer cases prefer chemotherapy in the US. Further, according to the same study, ~43.0% of the patients chose chemotherapy to treat large B-cells during 2012–2016. Thus, the consequent surge in adopting chemotherapies would eventually drive the demand for closed systems drug transfer devices in the coming years.
Based on the closing mechanism, the closed system drug transfer devices market is segmented into push-to-turn systems, color-to-color alignment systems, Luer-lock systems, and click-to-lock systems. The push-to-turn systems segment held the largest share of the market in 2019. However, the Luer-lock systems segment is anticipated to register the highest CAGR during the forecast period. Push-to-turn is one of the closing mechanisms that successfully prevents aerosol and vapor leakage from the vial. Increasing spending on healthcare professionals' occupational health and growing preference for chemotherapies are likely to drive the demand for closed system drug transfer devices, which will eventually drive the segment growth.
Get more information on this report :
Based on type, the closed system drug transfer devices market is segmented into a membrane-to-membrane system and needleless system. The membrane-to-membrane systems segment held the largest share of the market in 2019. However, the needleless systems segment is anticipated to register the highest CAGR in the market during the forecast period. The Membrane-to-membrane system prohibits the transfer of environmental contaminants into the system and leakage of hazardous gases outside the system. Moreover, the membrane-to-membrane system prevents the introduction of harmful vapor aerosols and spills outside the system with air-cleansing technology.
Based on technology, the closed system drug transfer devices market is segmented into diaphragm-based devices, compartmentalized devices, and air cleaning/filtration devices. The diaphragm-based devices systems segment held the largest share of the market in 2019. However, the compartmentalized devices segment is anticipated to register the highest CAGR in the market during the forecast period. Diaphragm-based devices are mainly used during pressure equalization. The technology prohibits the diffusion of hazardous vapors and offers protection from harmful exposure.
Based on component, the closed system drug transfer devices market is segmented into vial access devices, syringe safety devices, bag/line access devices, and accessories. The vial access devices segment held the largest share of the market in 2019. However, the syringe safety devices segment is anticipated to register the highest CAGR in the market during the forecast period. Vented vial access devices are used to access drugs for needleless drug preparation and administration safely. The vial access devices are projected to register considerable growth due to increasing drug administration. Moreover, vial access devices must be connected with the closed system drug transfer devices for drug administration.
Based on end user, the closed system drug transfer devices market is segmented into hospitals & clinics, oncology centers, and others. The hospitals & clinics segment held the largest share of the market in 2019 and also anticipated to register the highest CAGR in the market during the forecast period. The hospital segment is estimated to hold a considerable share as the majority of the patients in emerging nations and developed countries as well prefer to visit hospitals for any health-related problem. Further, an increasing number of hospitals and growing accessibility in emerging nations are also estimated to offer a lucrative opportunity to expand the hospital and clinics segment during the forecast period.
|Market Size Value in||US$ 374.48 Million in 2019|
|Market Size Value by||US$ 1,661.83 Million by 2027|
|Growth rate||CAGR of 20.5% from 2020-2027|
|No. of Pages||213|
|No. of Tables||118|
|No. of Charts & Figures||77|
|Historical data available||Yes|
|Segments covered||Closing Mechanism ; Type ; Technology ; Component ; End User , and Geography|
|Regional scope||North America; Europe; Asia Pacific; Latin America; MEA|
|Country scope||US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
Product launches, mergersand acquisitions, collaborations, and expansionsarethe commonly adopted strategies by various companies to expand their footprint worldwide and meet the growing demandby expanding theirrespective product portfolios.The players operating in the closed system drug transfer devices market adopted the product innovationsstrategy to cater to changing customer demand worldwide, which also permits them to maintain their brand name globally.
The List of Companies - Closed Systems Drug Transfer Devices Market